These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1311880)

  • 21. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma.
    Puniak MA; Freeman GM; Agresta CA; Van Newkirk L; Barone CA; Salzman SK
    J Neurotrauma; 1991; 8(3):193-203. PubMed ID: 1803028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotropin-releasing hormone: basis and potential for its therapeutic use.
    Kelly JA
    Essays Biochem; 1995; 30():133-49. PubMed ID: 8822153
    [No Abstract]   [Full Text] [Related]  

  • 24. Opiate antagonist in traumatic shock.
    McIntosh TK; Faden AI
    Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of TRH analogs in rat spinal cord injury.
    Faden AI; Sacksen I; Noble LJ
    Brain Res; 1988 May; 448(2):287-93. PubMed ID: 3132308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury.
    Amar AP; Levy ML
    Neurosurgery; 1999 May; 44(5):1027-39; discussion 1039-40. PubMed ID: 10232536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurochemical changes and current pharmacological approaches in craniocerebral trauma].
    Kossmann T; Lenzlinger PM; Stover JF; Stocker R; Morganti-Kossmann MC; Trentz O
    Unfallchirurg; 1997 Aug; 100(8):613-22. PubMed ID: 9381209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free radicals in CNS injury.
    Hall ED; Braughler JM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():81-105. PubMed ID: 8380240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyrotropin-releasing hormone and central nervous system trauma.
    Faden AI; Vink R; McIntosh TK
    Ann N Y Acad Sci; 1989; 553():380-4. PubMed ID: 2497681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of lipid peroxidation in CNS injury.
    Braughler JM; Hall ED
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S1-7. PubMed ID: 1588600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical treatment and neuroprotection in traumatic brain injury.
    Clausen T; Bullock R
    Curr Pharm Des; 2001 Oct; 7(15):1517-32. PubMed ID: 11562296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The thyrotropin releasing hormone (TRH) effect in experimental spinal cord trauma.
    Anghelescu N; Petrescu A; Cristescu C
    Neurol Psychiatr (Bucur); 1987; 25(4):239-47. PubMed ID: 3124256
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury.
    Gentile NT; McIntosh TK
    Ann Emerg Med; 1993 Jun; 22(6):1028-34. PubMed ID: 8099259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New pharmacologic approaches to acute spinal cord injury.
    Rhoney DH; Luer MS; Hughes M; Hatton J
    Pharmacotherapy; 1996; 16(3):382-92. PubMed ID: 8726596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock.
    Faden AI
    JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of single and combination drug treatment strategies in experimental brain trauma.
    Faden AI
    J Neurotrauma; 1993; 10(2):91-100. PubMed ID: 8411221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging strategies for the treatment of ischemic brain injury.
    Ginsberg MD
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():207-37. PubMed ID: 8417467
    [No Abstract]   [Full Text] [Related]  

  • 38. Lazaroids. CNS pharmacology and current research.
    Clark WM; Hazel JS; Coull BM
    Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment.
    Faden AI; Jacobs TP; Smith MT
    Neurology; 1984 Oct; 34(10):1280-4. PubMed ID: 6435011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries.
    Pitts LH; Ross A; Chase GA; Faden AI
    J Neurotrauma; 1995 Jun; 12(3):235-43. PubMed ID: 7473798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.